Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629)
04/2000
04/04/2000US6045802 Antitumor agents treating cancer
04/04/2000US6045792 Human proteins kinases
04/04/2000US6045791 Culturing the harvested retinal pigment epithelial cells from donor tissue on a culture substrate to form a monolayer, transferring to a non-toxic flexible support, then transplanting to the subretinal space in eye
04/04/2000US6045789 Bystander effect tumoricidal therapy by expressing an HSV-tk gene
04/04/2000CA2155933C Pulmonary administration of scr1 and other complement inhibitory proteins
04/04/2000CA2045475C Blood-coagulation factor xiia .beta. monoclonal antibody and immunoassay
04/04/2000CA2002540C Dna sequence coding for the human ix factor or a similar protein, expression vector, transformed cells, process for the preparation of ix factor and products obtained
04/04/2000CA1340942C Processes for the treatment of vascular disease
03/2000
03/30/2000WO2000017644A1 Ndp
03/30/2000WO2000017641A1 Gpr10 as a target for identifying weight modulating compounds
03/30/2000WO2000017624A2 Miniaturized cell array methods and apparatus for cell-based screening
03/30/2000WO2000017376A1 Replication deficient retroviral vector system and methods of using
03/30/2000WO2000017374A1 Retroviral particles protected against complement mediated destruction
03/30/2000WO2000017371A1 Polynucleotide constructs and uses thereof
03/30/2000WO2000017370A1 HUMAN COMPLEMENT C3-DEGRADING POLYPEPTIDE FROM $i(STREPTOCOCCUS PNEUMONIAE)
03/30/2000WO2000017369A2 Alzheimer's disease secretase
03/30/2000WO2000017364A2 Cyclin d polynucleotides, polypeptides and uses thereof
03/30/2000WO2000017362A1 Human interleukin-b50, therapeutic uses
03/30/2000WO2000017361A2 Interferon-epsilon
03/30/2000WO2000017358A2 Human chaperone proteins
03/30/2000WO2000017357A1 Methods and compositions relating to egf-repeat-containing polypeptides
03/30/2000WO2000017354A1 Human isre-binding protein
03/30/2000WO2000017353A1 Ucp4
03/30/2000WO2000017351A1 New human hepatoma-derived growth factor encoding sequence and polypeptide encoded by such dna sequence and producing method thereof
03/30/2000WO2000017350A1 New human growth differentiation factor encoding sequence and polypeptide encoded by such dna sequence and producing method thereof
03/30/2000WO2000017346A2 Hairpin hybridizer molecules for modulation of gene expression
03/30/2000WO2000017337A1 Expression vectors containing hot spot for increased recombinant protein expression in transfected cells
03/30/2000WO2000017331A1 A 2,6-β-D-FRUCTAN HYDROLASE ENZYME AND PROCESSES FOR USING THE ENZYME
03/30/2000WO2000017327A2 Terpene synthases
03/30/2000WO2000017326A1 Non-hematopoietic cells, including cardiomyocytes and skeletal muscle cells, derived from hematopoietic stem cells and methods of making and using them
03/30/2000WO2000017325A1 Trophoblast cell preparations
03/30/2000WO2000017323A1 Stable neural stem cell lines
03/30/2000WO2000017322A2 Electroactive materials for stimulation of biological activity of cells
03/30/2000WO2000017321A2 Use of growth factors and hormones for expansion of mammalian cells and tissue engineering
03/30/2000WO2000017235A2 Cytokine receptor zalpha11
03/30/2000WO2000017233A2 Genes of the 1-desoxy-d-xylulose biosynthetic pathway
03/30/2000WO2000017232A2 Regulatory protein from human keratinocytes
03/30/2000WO2000017226A1 Synthetic peptides, conjugation reagents and methods
03/30/2000WO2000017222A1 31 human secreted proteins
03/30/2000WO2000017221A1 Method of measuring protein-protein interactions in living cells
03/30/2000WO2000016818A1 Functionalized derivatives of hyaluronic acid and formation of hydrogels in situ using same
03/30/2000WO2000016817A1 Dermal scaffold using neutralized chitosan sponge or neutralized chitosan/collagen mixed sponge
03/30/2000WO2000016631A1 Murf2
03/30/2000WO2000016609A1 Novel method of regulating seed development in plants and genetic sequences therefor
03/30/2000WO2000008196A3 Urate oxidase
03/30/2000WO2000000609A3 Molecules associated with apoptosis
03/30/2000WO1999067393A3 Aav scleroprotein, production and use thereof
03/30/2000WO1999064593A3 Cell cycle regulation proteins
03/30/2000WO1999063101A9 Transfected cells and methods for treating diabetes
03/30/2000WO1999061597A3 Expression cassette for transformation comprising a modified viral sequence driven by a suitable promoter
03/30/2000WO1999060127A9 Il-17 homologous polypeptides and therapeutic uses thereof
03/30/2000WO1999055831A3 Adenoviral vectors for treating disease
03/30/2000WO1999053055A3 Therapeutic agent for ngf
03/30/2000WO1999051744A3 A interleukin-1 receptor antagonist and uses thereof
03/30/2000WO1999042477A3 Transporter protein for saccharide-coupled medicaments
03/30/2000DE19856261C1 Detection of gamma-secretase by detection of A-beta peptide useful for determining gamma-secretase activity and for identifying inhibitors
03/30/2000CA2345397A1 Trophoblast cell preparations
03/30/2000CA2345392A1 Method of measuring protein-protein interactions in living cells
03/30/2000CA2345151A1 Miniaturized cell array methods and apparatus for cell-based screening
03/30/2000CA2345088A1 Gpr10 as a target for identifying weight modulating compounds
03/30/2000CA2344699A1 Expression vectors containing hot spot for increased recombinant protein expression in transfected cells
03/30/2000CA2344657A1 Human isre-binding protein
03/30/2000CA2344399A1 Use of growth factors and hormones for expansion of mammalian cells and tissue engineering
03/30/2000CA2344215A1 Functionalized derivatives of hyaluronic acid and formation of hydrogels in situ using same
03/30/2000CA2344100A1 31 human secreted proteins
03/30/2000CA2343978A1 Novel method of regulating seed development in plants and genetic sequences therefor
03/30/2000CA2343931A1 Human complement c3-degrading polypeptide from streptococcus pneumoniae
03/30/2000CA2343919A1 Genes of the 1-desoxy-d-xylulose biosynthetic pathway
03/30/2000CA2343697A1 Cyclin d polynucleotides, polypeptides and uses thereof
03/30/2000CA2343360A1 Human cytoskeleton associated proteins
03/30/2000CA2343353A1 Methods and compositions relating to egf-repeat-containing polypeptides
03/30/2000CA2343324A1 Polynucleotide constructs and uses thereof
03/30/2000CA2343090A1 Retroviral particles protected against complement mediated destruction
03/30/2000CA2343070A1 A 2,6-.beta.-d-fructan hydrolase enzyme and processes for using the enzyme
03/30/2000CA2343067A1 Hairpin hybridizer molecules for modulation of gene expression
03/30/2000CA2343004A1 Alzheimer's disease secretase
03/30/2000CA2342957A1 Regulatory protein from human keratinocytes
03/30/2000CA2342773A1 Interferon-epsilon
03/30/2000CA2342053A1 Modified tobacco 5-epi-aristolochene synthases
03/29/2000EP0989184A1 A transgenic coagulation factor XIII defective animal and its use for testing wound healing and bleeding
03/29/2000EP0988860A1 NKT CELL ACTIVATORS CONTAINING $g(a)-GLYCOSYLCERAMIDES
03/29/2000EP0988391A2 Recombinant adenoviral vectors comprising a splicing sequence
03/29/2000EP0988388A2 Ghrh expression system and methods of use
03/29/2000EP0988384A1 New beta-glucanase from a bacillus
03/29/2000EP0988381A1 T-cell receptor beta-like protein
03/29/2000EP0988380A1 Translational regulator initiation factor 4e-binding protein
03/29/2000EP0988376A2 Noey2 gene compositions and methods of use
03/29/2000EP0988373A1 Selection marker
03/29/2000EP0988371A1 Human tumor necrosis factor receptor tr9
03/29/2000EP0988319A1 Human l105 proteins and polynucleotides encoding same
03/29/2000EP0988318A2 Human extracellular matrix proteins
03/29/2000EP0988317A2 Aib1, a steroid receptor co-activator
03/29/2000EP0988048A1 Ligand/lytic peptide compositions and methods of use
03/29/2000EP0988047A1 Soluble ctla4 mutant molecules and uses thereof
03/29/2000EP0987998A1 Tissue decellularization
03/29/2000EP0987941A1 Improvements to methods for preparing equine embryos for cryopreservation
03/29/2000EP0987936A1 Fatty acid desaturases and mutant sequences thereof
03/29/2000EP0777689B1 Use of cytadherence peptides for use in modifying mutual adhesion among eukaryotic cells
03/29/2000CN1249000A Method for separating cells
03/29/2000CN1248630A Processf or producing taxus alkane diterpene
1 ... 1516 1517 1518 1519 1520 1521 1522 1523 1524 1525 1526 1527 1528 1529 1530 1531 1532 1533 1534 1535 1536 ... 1827